Dopamine oxidation facilitates rotenone-dependent potentiation of N-methyl-d-aspartate currents in rat substantia nigra dopamine neurons

Neuroscience

Volumn 195, Issue , 2011, Pages 138-144

  Wu, Y N ^a   Johnson, S W ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Monoamine oxidase; N methyl d aspartate; Pargyline; Reactive oxygen species; Reserpine; Rotenone

Indexed keywords

ACETYLCYSTEINE; AMINE OXIDASE (FLAVIN CONTAINING); DOPAMINE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; LEVODOPA; METIROSINE; N METHYL DEXTRO ASPARTIC ACID; PARGYLINE; REACTIVE OXYGEN METABOLITE; RESERPINE; ROTENONE; THIOMALIC ACID;

ANIMAL TISSUE; ARTICLE; CELL TRANSPORT; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINE OXIDATION; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; ENZYME INHIBITION; MALE; MESENCEPHALON; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; TISSUE LEVEL;

ANIMALS; DOPAMINE; MALE; MEMBRANE POTENTIALS; N-METHYLASPARTATE; NEURONS; OXIDATION-REDUCTION; PARKINSONIAN DISORDERS; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; ROTENONE; SUBSTANTIA NIGRA; UNCOUPLING AGENTS;

EID: 80053567313     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.08.041     Document Type: Article

References (53)

1. Aizenman E., Hartnett K.A., Reynolds I.J. Oxygen free radicals regulate NMDA receptor function via a redox modulatory site. Neuron 1990, 5:841-846.
2. Alam M., Schmidt W.J. L-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated rats. Behav Brain Res 2004, 153:439-446.
3. Avshalumov M.V., Chen B.T., Koós T., Tepper J.M., Rice M.E. Endogenous hydrogen peroxide regulates the excitability of midbrain dopamine neurons via ATP-sensitive potassium channels. J Neurosci 2005, 25:4222-4231.
4. Benecke R., Strumper P., Weiss H. Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes. Brain 1993, 116:1451-1463.
5. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 2000, 3:1301-1306.
6. Burke W.J., Li S.W., Chung H.D., Ruggiero D.A., Kristal B.S., Johnson E.M., Lampe P., Kumar V.B., Franko M., Williams E.A., Zahm D.S. Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: role in neurodegenerative diseases. Neurotoxicology 2004, 25:101-115.
7. Bywood P.T., Johnson S.M. Mitochondrial complex inhibitors preferentially damage substantia nigra dopamine neurons in rat brain slices. Exp Neurol 2003, 179:47-59.
8. 2+ block of NMDA-receptor channels as a mechanism of modulation. Nature 1992, 356:521-523.
9. Choi D.W. Excitotoxic cell death. J Neurobiol 1992, 23:1261-1276.
10. Dukes A.A., Korwek K.M., Hastings T.G. The effect of endogenous dopamine in rotenone-induced toxicity in PC12 cells. Antioxid Redox Signal 2005, 7:630-638.
11. Giannoni E., Buricchi F., Raugei G., Ramponi G., Chiarugi P. Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth. Mol Cell Biol 2005, 25:6391-6403.
12. Grace A.A., Onn S.-P. Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro. J Neurosci 1989, 9:3463-3481.
13. Hara M.R., Snyder S.H. Cell signaling and neuronal death. Annu Rev Pharmacol Toxicol 2007, 47:117-141.
14. Hasbani D.M., Perez F.A., Palmiter R.D., O'Malley K.L. Dopamine depletion does not protect against acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in vivo. J Neurosci 2005, 25:9428-9433.
15. Kress G.J., Reynolds I.J. Dopaminergic neurotoxins require excitotoxic stimulation in organotypic cultures. Neurobiol Dis 2005, 20:639-645.
16. Kristal B.S., Conway A.D., Brown A.M., Jain J.C., Ulluci P.A., Li S.W., Burke W.J. Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria. Free Radic Biol Med 2001, 30:924-931.
17. 2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta. J Physiol (Lond) 1987, 392:397-416.
18. 2 dopamine receptor supersensitivity as indicated by striatal and pallidal Fos expression. Neurosci Lett 1994, 179:153-156.
19. Lamensdorf I., Eisenhofer G., Harvey-White J., Nechustan A., Kirk K., Kopin I.J. 3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells. Brain Res 2000, 868:191-201.
20. Lipton S.A., Choi Y.-B., Takahashi H., Zhang D., Li W., Godzik A., Bankston L.A. Cysteine regulation of protein function-as exemplified by NMDA-receptor modulation. Trends Neurosci 2002, 25:474-480.
21. Liu H., Zhu X.-Z., Weng E. Intracellular dopamine oxidation mediates rotenone-induced apoptosis in PC12 cells. Acta Pharmacol Sin 2005, 26:17-26.
22. Lotharius J., O'Malley K.L. The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity. J Biol Chem 2000, 275:38581-38588.
23. Majewska M.D., Bell J.A., London E.D. Regulation of the NMDA receptor by redox phenomena: inhibitory role of ascorbate. Brain Res 1990, 537:328-332.
24. Marey-Semper I., Gelman M., Levi-Strauss M. A selective toxicity toward cultured mesencephalic dopaminergic neurons is induced by the synergic effects of energetic metabolism impairment and NMDA receptor activation. J Neurosci 1995, 15:5912-5918.
25. 2-induced phosphorylation of ERK1/2 and PKB requires tyrosine kinase activity of insulin receptor and c-Src. Antioxid Redox Signal 2005, 7:1014-1020.
26. Mena M.A., Pardo B., Caserejos M.J., Fahn S., de Yebenes J.G. Neurotoxicity of levodopa on catecholamine-rich neurons. Mov Disord 1992, 7:23-31.
27. Mercuri N.B., Scarponi M., Bonci A., Siniscalchi A., Bernardi G. Monoamine oxidase inhibition causes a long-term prolongation of the dopamine-induced responses in rat midbrain dopaminergic cells. J Neurosci 1997, 17:2267-2272.
28. Mizuno Y., Ohta S., Tanaka M., Takamiya S., Suzuki K., Sato T., Oya H., Ozawa T., Kagawa Y. Deficiencies in complex I subunits of the repiratory chain in Parkinson's disease. Biochem Biophys Res Commun 1989, 163:1450-1455.
29. Moriguchi S., Shioda N., Maejima H., Zhao X., Marszalec W., Yeh J.Z., Fukunaga K., Narahashi T. Nefiracetam potentiates N-methyl-d-aspartate (NMDA) receptor function via protein kinase C activation and reduces magnesium block of NMDA receptor. Mol Pharmacol 2007, 71:580-587.
30. Mytilineau C., Walker R.H., Jnobaptiste R., Olanow C.W. Levodopa is toxic to dopamine neurons in an in vitro but not an in vivo model of oxidative stress. J Pharmacol Exp Ther 2003, 304:792-800.
31. Mytilineou C., Cohen G. Deprenyl protects dopamine neurons from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion. J Neurochem 1985, 45:1951-1953.
32. Naudin B., Bonnet J.-J., Costentin J. Acute l-dopa pretreatment potentiates 6-hydroxydopamine-induced toxic effects on nigro-striatal dopamine neurons in mice. Brain Res 1995, 701:151-157.
33. Olanow C.W. Oxidative reactions in Parkinson's disease. Neurologist 1990, 40(Suppl 3):32-37.
34. Parker W.D., Boyson S.J., Parks J.K. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann Neurol 1989, 26:719-723.
35. Radad K., Rausch W.D., Gille G. Rotenone induces cell death in primary dopaminergic culture by increasing ROS production and inhibiting mitochondrial respiration. Neurochem Int 2006, 49:379-386.
36. Rajput A.H., Fenton M.E., Birdi S., Macaulay R. Is levodopa toxic to human substantia nigra?. Mov Disord 1997, 12:634-638.
37. Rees J.N., Florang V.R., Eckert L.L., Doorn J.A. Protein reactivity of 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite, is dependent on both the aldehyde and catechol. Chem Res Toxicol 2009, 22:1256-1263.
38. Riley D. Is levodopa toxic to human substantia nigra?. Mov Disord 1998, 13:369-370.
39. Röper J., Ashcroft F.M. Metabolic inhibition and low internal ATP activate K-ATP channels in rat dopaminergic substantia nigra neurones. Pflugers Arch 1995, 430:44-54.
40. Sakka N., Sawada H., Izumi Y., Kume T., Katsuki H., Kaneko S., Shimohama S., Akaike A. Dopamine is involved in selectivity of dopaminergic neuronal death by rotenone. Neuroreport 2008, 14:2425-2428.
41. Saravanan K.S., Sindhu K.M., Senthilkumar K.S., Mohanakumar K.P. l-Deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats. Neurochem Int 2006, 49:28-40.
42. Schapira A.H.V., Cooper J.M., Dexter D., Jenner P., Clark J.B., Marsden C.D. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 1990, 54:823-827.
43. Seaton T.A., Cooper J.M., Schapira A.H. Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors. Brain Res 1997, 777:110-118.
44. Sherer T.B., Betarbet R., Testa C.M., Seo B.B., Richardson J.R., Kim J.H., Miller G.W., Yagi T., Matsuno-Yagi A., Greenamyre J.T. Mechanism of toxicity in rotenone models of Parkinson's disease. J Neurosci 2003, 23:10756-10764.
45. Sulzer D., Zecca L. Intraneuronal dopamine-quinone synthesis: a review. Neurotox Res 2000, 1:181-195.
46. Toussaint O., Houbion A., Remacle J. Relationship between the critical level of oxidative stresses and the glutathione peroxidase activity. Toxicology 1993, 81:89-101.
47. 14C-2-deoxyglucose autoradiography. J Neurosci 1992, 12:2875-2879.
48. Wu Y.-N., Johnson S.W. Rotenone potentiates NMDA currents in substantia nigra dopamine neurons. Neurosci Lett 2007, 421:96-100.
49. 2+-dependent block of NMDA currents in substantia nigra dopamine neurons. Neurotoxicology 2009, 30:320-325.
50. Wu Y.-N., Martella G., Johnson S.W. Rotenone enhances NMDA currents by activating a tyrosine kinase in rat dopamine neurons. Neuroreport 2007, 18:1813-1816.
51. Wu Y.-N., Munhall A.C., Johnson S.W. Mitochondrial uncoupling agents antagonize rotenone actions in rat substantia nigra dopamine neurons. Brain Res 2011, 1395:86-93.
52. Xiong Z.-G., Raouf R., Lu W.-Y., Wang L.-Y., Orser B.A., Dudek E.M., Browning M.D., MacDonald J.F. Regulation of N-methyl-d-aspartate receptor function by constitutively active protein kinase C. Mol Pharmacol 1998, 54:1055-1063.
53. Yadava N., Nicholls D.G. Spare respiratory capacity rather than oxidative stress regulates glutamate excitotoxicity after partial respiratory inhibition of mitochondrial complex I with rotenone. J Neurosci 2008, 27:7310-7317.